西雅图，美国 – 2025年2月20日 – 科亚医疗（Keya Medical） 与 CARPL.ai 隆重宣布达成战略合作，旨在加速全球临床放射学工作流程中先进人工智能（AI）解决方案的集成。此次合作将结合科亚医疗在心血管成像领域的尖端技术与 CARPL.ai 的厂商中立 AI 平台，以提升诊断精确性和医疗服务效率。

Seattle, USA – February 20, 2025 – Keya Medical and CARPL.ai are excited to announce a strategic collaboration aimed at accelerating the integration of advanced AI solutions in clinical radiology workflows worldwide. This partnership will combine Keya Medical’s cutting-edge cardiovascular imaging technology with CARPL.ai’s leading vendor-neutral AI platform, enhancing diagnostic precision and clinical efficiency for healthcare providers.

CARPL.ai 是全球卓越的放射学 AI 市场，提供来自 65+ 家 AI 供应商 的 150 多款应用程序。凭借其统一的用户界面、单一数据通道和简化的采购系统，CARPL.ai 能够帮助放射科医生轻松访问、评估并集成 AI 解决方案到临床实践中。

CARPL.ai is the world’s largest radiology AI marketplace, offering over 150 applications from 65+ AI vendors. With its unified user interface, single data channel, and streamlined procurement system, CARPL.ai empowers radiologists to easily access, assess, and integrate AI solutions into clinical practice.

通过此次合作，科亚医疗 将利用 CARPL.ai 的平台拓展其先进心血管解决方案的全球覆盖，帮助医疗专业人士在日常工作中无缝融入 AI 驱动的诊断工具。双方还将共同开展研究项目，推动创新 AI 工具的应用，从而改善患者的诊疗效果。

Through this collaboration, Keya Medical will leverage CARPL.ai’s platform to broaden the reach of its advanced cardiovascular solutions, allowing healthcare professionals to seamlessly incorporate AI-powered diagnostics into their daily workflows. This partnership will also foster joint research initiatives and enable the deployment of innovative AI tools that drive better patient outcomes.

科亚医疗顾问委员会成员秦明阳先生表示：“我们与 CARPL.ai 的合作是加强全球对前沿 AI 心血管解决方案获取能力的重要一步。我们希望通过这次合作为放射科医生提供更高效、更精准的诊断工具，从而提升全球范围内的医疗服务质量。”

“Our collaboration with CARPL.ai marks a significant step toward enhancing global access to cutting-edge AI-driven cardiovascular solutions,” said Nathan Qin, Global Business Advisory Board member at Keya Medical. “Together, we aim to empower radiologists with tools that improve diagnostic accuracy and patient care on a global scale.”

此次战略合作充分体现了双方致力于推动人工智能在医疗领域的应用，并为临床医生提供更快速、更精准诊断支持的坚定承诺。

This strategic partnership underscores both organizations’ commitment to advancing AI adoption in healthcare and supporting clinicians in delivering faster, more accurate diagnoses.